Literature DB >> 17242884

Regulation and functional roles of sphingosine kinases.

Regina Alemany1, Chris J van Koppen, Kerstin Danneberg, Michael Ter Braak, Dagmar Meyer Zu Heringdorf.   

Abstract

Sphingosine kinases (SphKs) catalyze the phosphorylation of sphingosine to sphingosine-1-phosphate (S1P). Together with other sphingolipid metabolizing enzymes, SphKs regulate the balance of the lipid mediators, ceramide, sphingosine, and S1P. The ubiquitous mediator S1P regulates cellular functions such as proliferation and survival, cytoskeleton architecture and Ca(2+) homoeostasis, migration, and adhesion by activating specific high-affinity G-protein-coupled receptors or by acting intracellularly. In mammals, two isoforms of SphK have been identified. They are activated by G-protein-coupled receptors, receptor tyrosine kinases, immunoglobulin receptors, cytokines, and other stimuli. The molecular mechanisms by which SphK1 and SphK2 are specifically regulated are complex and only partially understood. Although SphK1 and SphK2 appear to have opposing roles, promoting cell growth and apoptosis, respectively, they can obviously also substitute for each other, as mice deficient in either SphK1 or SphK2 had no obvious abnormalities, whereas double-knockout animals were embryonic lethal. In this review, our understanding of structure, regulation, and functional roles of SphKs is updated and discussed with regard to their implication in pathophysiological and disease states.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17242884     DOI: 10.1007/s00210-007-0132-3

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  130 in total

1.  Functional characterization of human sphingosine kinase-1.

Authors:  V E Nava; E Lacana; S Poulton; H Liu; M Sugiura; K Kono; S Milstien; T Kohama; S Spiegel
Journal:  FEBS Lett       Date:  2000-05-04       Impact factor: 4.124

Review 2.  The ins and outs of sphingolipid synthesis.

Authors:  Anthony H Futerman; Howard Riezman
Journal:  Trends Cell Biol       Date:  2005-06       Impact factor: 20.808

3.  CpG island of rat sphingosine kinase-1 gene: tissue-dependent DNA methylation status and multiple alternative first exons.

Authors:  T Imamura; J Ohgane; S Ito; T Ogawa; N Hattori; S Tanaka; K Shiota
Journal:  Genomics       Date:  2001-08       Impact factor: 5.736

4.  Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes.

Authors:  S M Pitson; R J D'andrea; L Vandeleur; P A Moretti; P Xia; J R Gamble; M A Vadas; B W Wattenberg
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

Review 5.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04

6.  Sphingosine kinase transmits estrogen signaling in human breast cancer cells.

Authors:  Olga A Sukocheva; Lijun Wang; Nathaniel Albanese; Stuart M Pitson; Mathew A Vadas; Pu Xia
Journal:  Mol Endocrinol       Date:  2003-07-24

Review 7.  Lysophospholipid receptors: signaling and biology.

Authors:  Isao Ishii; Nobuyuki Fukushima; Xiaoqin Ye; Jerold Chun
Journal:  Annu Rev Biochem       Date:  2004       Impact factor: 23.643

8.  Ligand-dependent inhibition of B16 melanoma cell migration and invasion via endogenous S1P2 G protein-coupled receptor. Requirement of inhibition of cellular RAC activity.

Authors:  Kayo Arikawa; Noriko Takuwa; Hironori Yamaguchi; Naotoshi Sugimoto; Joji Kitayama; Hirokazu Nagawa; Kazuhiko Takehara; Yoh Takuwa
Journal:  J Biol Chem       Date:  2003-06-16       Impact factor: 5.157

9.  The calmodulin-binding site of sphingosine kinase and its role in agonist-dependent translocation of sphingosine kinase 1 to the plasma membrane.

Authors:  Catherine M Sutherland; Paul A B Moretti; Niamh M Hewitt; Christopher J Bagley; Mathew A Vadas; Stuart M Pitson
Journal:  J Biol Chem       Date:  2006-03-06       Impact factor: 5.157

10.  Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis.

Authors:  Puneet S Jolly; Meryem Bektas; Ana Olivera; Claudia Gonzalez-Espinosa; Richard L Proia; Juan Rivera; Sheldon Milstien; Sarah Spiegel
Journal:  J Exp Med       Date:  2004-04-05       Impact factor: 14.307

View more
  85 in total

1.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

2.  Sphingosine kinase 1 is critically involved in nitric oxide-mediated human endothelial cell migration and tube formation.

Authors:  Stephanie Schwalm; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

Review 3.  Sphingosine kinase regulation and cardioprotection.

Authors:  Joel S Karliner
Journal:  Cardiovasc Res       Date:  2008-11-18       Impact factor: 10.787

4.  Combined anticancer effects of sphingosine kinase inhibitors and sorafenib.

Authors:  Vladimir Beljanski; Christian Knaak; Yan Zhuang; Charles D Smith
Journal:  Invest New Drugs       Date:  2010-05-18       Impact factor: 3.850

5.  Periodontal inflammation and alveolar bone loss induced by Aggregatibacter actinomycetemcomitans is attenuated in sphingosine kinase 1-deficient mice.

Authors:  H Yu; C Sun; K M Argraves
Journal:  J Periodontal Res       Date:  2015-04-20       Impact factor: 4.419

Review 6.  Sphingolipids in inflammation: pathological implications and potential therapeutic targets.

Authors:  Graeme F Nixon
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

7.  Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney.

Authors:  R Jason Kirby; Ying Jin; Jian Fu; Jimena Cubillos; Debi Swertfeger; Lois J Arend
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

8.  The sphingosine kinase inhibitor N,N-dimethylsphingosine inhibits neointimal hyperplasia.

Authors:  Robert A McDonald; Susan Pyne; Nigel J Pyne; Anne Grant; Cherry L Wainwright; Roger M Wadsworth
Journal:  Br J Pharmacol       Date:  2009-12-15       Impact factor: 8.739

9.  Potentiation of cannabinoid-induced cytotoxicity in mantle cell lymphoma through modulation of ceramide metabolism.

Authors:  Kristin Gustafsson; Birgitta Sander; Jacek Bielawski; Yusuf A Hannun; Jenny Flygare
Journal:  Mol Cancer Res       Date:  2009-07       Impact factor: 5.852

Review 10.  Targeting sphingosine-1-phosphate signaling in lung diseases.

Authors:  David L Ebenezer; Panfeng Fu; Viswanathan Natarajan
Journal:  Pharmacol Ther       Date:  2016-09-13       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.